Detection, Distribution and Inhibition of Branhamella catarrhalis β-Lactamases
暂无分享,去创建一个
[1] M. Jones,et al. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis , 1985, Antimicrobial Agents and Chemotherapy.
[2] A. Verghese,et al. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains , 1985, Antimicrobial Agents and Chemotherapy.
[3] C. Kamme,et al. Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. , 1985, The Journal of antimicrobial chemotherapy.
[4] A. Seaton,et al. Bronchopulmonary infection due to Branhamella catarrhalis. , 1983, British medical journal.
[5] C. Reading,et al. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid , 1982, Antimicrobial Agents and Chemotherapy.
[6] M. Miller,et al. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. , 1981, Archives of internal medicine.
[7] P. Courvalin,et al. Antibiotic susceptibility testing of Neisseria gonorrhoeae by disk-agar diffusion. , 1981, Annales de microbiologie.
[8] K. Coleman,et al. In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin. , 1980, The Journal of antimicrobial chemotherapy.
[9] R. Wise,et al. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins. , 1980, The Journal of antimicrobial chemotherapy.
[10] G. Doern,et al. Antibiotic Susceptibility of Beta-Lactamase-Producing Strains of Branhamella (Neisseria) catarrhalis , 1980, Antimicrobial Agents and Chemotherapy.
[11] R. Labia,et al. Novel beta-lactamase from Branhamella catarrhalis. , 1978, Annales de microbiologie.
[12] R. Labia,et al. Beta-Lactamases: Determination of Their Isoelectric Points , 1978, Antimicrobial Agents and Chemotherapy.
[13] R. Sykes,et al. PATHOGENICITY OF AND β-LACTAMASE PRODUCTION BY BRANHAMELLA (NEISSERIA) CATARRHALIS , 1977, The Lancet.
[14] P. Piot,et al. BRANHAMELLA (NEISSERIA) CATARRHALIS AS PATHOGEN , 1977, The Lancet.
[15] A. Harris,et al. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.
[16] C. P. V. Boven,et al. Branhamella catarrhalis: antibiotic sensitivities and β-lactamases , 1984 .
[17] C. Kamme,et al. Transfer of beta-lactamase production in Branhamella catarrhalis. , 1983, Scandinavian journal of infectious diseases.
[18] C. Kamme,et al. Transfer of β-Lactamase Production in Branhamella catarrhalis , 1983 .
[19] R. Labia,et al. Properties of three carbenicillin-hydrolysing beta-lactamases (CARB) from Pseudomonas aeruginosa: identification of a new enzyme. , 1981, The Journal of antimicrobial chemotherapy.
[20] J. Johnsson,et al. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis. , 1977, The Journal of antimicrobial chemotherapy.
[21] J. Riou,et al. [Bacteriological diagnosis of species of the genera Neisseria and Branhamella]. , 1977, Annales de biologie clinique.